BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 04:41 am EDT
BrightGene Bio-Medical Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 248.37 million compared to CNY 188.84 million a year ago. Revenue was CNY 248.37 million compared to CNY 188.84 million a year ago. Net income was CNY 60.75 million compared to CNY 48.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.12 a year ago. Diluted earnings per share from continuing operations was CNY 0.15 compared to CNY 0.12 a year ago.